TGFB1 and liver dysplastic nodule: We highlight its potential mechanisms of action, including suppression of inflammation and oxidative stress, inhibition of TGF-β1–mediated renal fibrosis, protection of podocyte function, and induction of ferroptosis, and discuss the possible synergistic interactions among these effects in modulating the DN disease network.